Delivery Order SPE2DR25D3202-SPE2DR26F8E5F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,908.31 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $33,819.84 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency awarded a delivery order valued at $9,311.92 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on January 8, 2026, with completion expected by January 9, 2026. This is a firm fixed-price, non-set-aside contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical product will be delivered to AmerisourceBergen's place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,330.33 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a $8,837.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on January 15, 2026, with completion targeted for January 16, 2026. This is a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $9,798.05 under a firm fixed-price contract type. The award was made on October 15, 2025, with an ultimate completion date of October 16, 2025, and represents a non-competitive, open-competition procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $16,239.21 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) under a firm fixed-price contract. The award, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $41,898.36 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed-price contract. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E5FDelivery Order
The Defense Logistics Agency awarded a $14.87K firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on January 14, 2026, with completion scheduled for January 15, 2026. This non-set-aside award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and critical medical commodities across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance under its parent's DLA contract demonstrates consistent capability to compete successfully on a full and open basis and efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 1/13/26 |